2011-21042. Dialogues in Diversifying Clinical Trials: Successful Strategies for Engaging Women and Minorities in Clinical Trials  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice of meeting.

    The Food and Drug Administration (FDA) is announcing the following Office of Women's Health and Society for Women's Health Research jointly sponsored meeting: Dialogues in Diversifying Clinical Trials: Successful Strategies for Engaging Women and Minorities in Clinical Trials. The purpose of this symposium is to facilitate the broader discussion and dissemination of innovative strategies for increasing the recruitment and retention of women and minority subpopulations into clinical trials. The overarching goal of this symposium is to use a best practices learning exchange to share information and encourage successful methods and/or model implementation within a broad research community—industry, academia, and government.

    Date and Time: The meeting will be held on September 22, 2011, from 8 a.m. to 9 a.m. (registration); 9 a.m. to 5:30 p.m. (program); 5:30 p.m. to 6:30 p.m. (reception); and September 23, from 8 a.m. to 1:30 p.m.

    Location: The meeting will be held at L'Enfant Plaza Hotel, 480 L'Enfant Plaza, SW., Washington, DC 20024.

    Contact: Deborah Kallgren, FDA Office of Women's Health, 10903 New Hampshire Ave., Bldg. 32, Rm. 2314, Silver Spring, MD 20993-0002, 301-796-9442, Fax: 301-847-8604, e-mail: deborah.kallgren@fda.hhs.gov.

    Registration: Registration is free, but seating is limited to 200. Registration will be accepted online and is available at http://www.swhr.org through September 16, 2011. For information regarding registration contact: Rachel Griffith, Society for Women's Health Research (SWHR), 1025 Connecticut Ave., NW., Suite 701, Washington, DC 20036, 202-496-5001, Fax: 202-833-3472, e-mail: rachel@swhr.org.

    If you need special accommodations due to a disability, please contact Rachel Griffith at least 7 days in advance.

    Start Signature

    Dated: August 12, 2011.

    Leslie Kux,

    Acting Assistant Commissioner for Policy.

    End Signature End Preamble

    [FR Doc. 2011-21042 Filed 8-17-11; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Comments Received:
0 Comments
Published:
08/18/2011
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice of meeting.
Document Number:
2011-21042
Pages:
51375-51375 (1 pages)
Docket Numbers:
Docket No. FDA-2011-N-0002
PDF File:
2011-21042.pdf